Stock Report

All about this stock under one free report Last Updated: 28-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

MorphoSys AG - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$18.96

up-down-arrow $-- (--%)

As on 09-Aug-2024 09:30EDT

Market cap

info icon

$2,856 Mln

Revenue (TTM)

info icon

$204 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

53.8

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -53.38 -55.81 -31.94 18.08 18.48
EBIT -1,163.33 -1,481.89 -268.32 -192.79 -227.34
Net Profit -752.56 -617.67 -536.29 -185.34 -241.91
EPS -786.77 -551.82 -504.26 -173.03 -236.65
Book Value -- -- -73.11 -59.73 -39.65
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-23Dec-22
EBIT-Margin info -31.34-40.82-165.32-46.9858.36
Net Margin info ---143.56-226.08----
Return on equity info -125.90-76.35---183.80-75.10
Return on Capital info -42.85-27.14---32.11-28.30
Return on Assets info -13.03-9.98-18.41-8.58-6.10
Debt to Equity (x) info ----0.0012.972.16

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
-32.11
-28.30
-68.14
14.22
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
-183.80
-75.10
-118.80
19.27
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-18.41

Lower than Peers by 5.45

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-18.41
-8.58
-6.10
-24.41
9.08
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-165.32

Lower than Peers by 105.62

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-165.32
-46.98
58.36
-105.40
36.44
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-226.08

Lower than Peers by 155.02

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-226.08
-79.63
-54.29
-286.47
29.87
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
0.00
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-31.94

Lower than Peers by 52.50

Year on year growth in net sales

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-31.94
-0.14
0.55
-0.45
3.57
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-268.32

Lower than Peers by 283.51

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-268.32
-168.94
185.79
-258.51
213.59
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-536.29

Lower than Peers by 544.15

Year on year growth in profit after tax

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-536.29
-25.60
70.64
-625.59
195.03
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-504.26

Lower than Peers by 535.30

Year on year growth in earnings per share

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-504.26
-0.08
0.71
-6.04
1.92
Peer Median
31.05
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-344.94

Lower than Peers by 346.18

Year on year growth in book value per share

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-344.94
--
--
--
--
Peer Median
1.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
12.97
2.16
1.33
0.51
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.02

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-0.02
0.29
0.06
0.01
0.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.38

Lower than Peers by 2.10

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
1.38
3.08
3.91
3.98
6.02
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.38

Lower than Peers by 1.90

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
1.38
2.84
3.83
3.91
5.97
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-3.26

Lower than Peers by 2.29

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
-3.26
-1.02
1.39
-1.04
1.24
Peer Median
-0.97
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

15.14

Lower than Peers by 9.18

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
15.14
17.90
40.38
47.77
27.41
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.08

Lower than Peers by 0.15

Sales / Average Total Assets

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
0.08
0.11
0.11
0.09
0.30
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
118.80
130.04
178.58
61.40
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
270.15
169.06
174.22
204.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
209.58
422.07
688.22
1,158.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-23
Dec-22
Dec-21
Dec-20
MorphoSys AG - ADR
--
179.37
-122.97
-335.42
-893.38
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...